Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013)
Bio-Rad Laboratories' (BIO) quarterly Income from Non-Controlling Interests came in at $21000.0 in Q1 2013, up 134.43% year-over-year from $8958.0 in Q1 2012, and up 126.58% quarter-over-quarter from -$79000.0 in Q4 2012.
Analysis
Bio-Rad Laboratories (BIO) Income from Non-Controlling Interests (2009 - 2013) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Income from Non-Controlling Interests for 5 consecutive years, with $21000.0 the latest figure, recorded in Q1 2013.
- On a quarterly basis, Income from Non-Controlling Interests rose 134.43% year-over-year to $21000.0 in Q1 2013; TTM through Dec 2013 was $21000.0, a 69.57% decrease from a year earlier, with the FY2013 full-year figure at $21000.0, down 69.57% from the prior year.
- Income from Non-Controlling Interests was $21000.0 for Q1 2013 at Bio-Rad Laboratories, up from -$79000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $776000.0 in Q3 2009 and troughed at -$1.3 million in Q2 2009.
- A 5-year average of $90000.0 and a median of $4000.0 in 2012 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests plunged 231.03% in 2011 and jumped 953.85% in 2012, its largest moves.
- Over 5 years, Income from Non-Controlling Interests stood at $660000.0 in 2009, then slumped by 95.61% to $29000.0 in 2010, then sank by 231.03% to -$38000.0 in 2011, then sank by 107.89% to -$79000.0 in 2012, then soared by 126.58% to $21000.0 in 2013.
- The last three Income from Non-Controlling Interests figures came in at $21000.0 (Q1 2013), -$79000.0 (Q4 2012), and -$13000.0 (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 21,000.00 |
| Dec 31, 2012 | -79,000.00 |
| Sep 30, 2012 | -13,000.00 |
| Jun 30, 2012 | 222,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Sep 30, 2011 | -35,000.00 |
| Jun 30, 2011 | -26,000.00 |
| Mar 31, 2011 | -101,000.00 |
| Dec 31, 2010 | 29,000.00 |
| Sep 30, 2010 | 321,000.00 |
| Jun 30, 2010 | 564,000.00 |
| Mar 31, 2010 | 531,000.00 |
| Dec 31, 2009 | 660,000.00 |
| Sep 30, 2009 | 776,000.00 |
| Jun 30, 2009 | -1.33 Mn |